Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cell Tracking | 2 | 2021 | 147 | 0.930 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome, Type 1 | 1 | 2021 | 3 | 0.840 |
Why?
|
Hyper-IgM Immunodeficiency Syndrome | 1 | 2021 | 9 | 0.840 |
Why?
|
Hematopoietic Stem Cells | 9 | 2023 | 3394 | 0.690 |
Why?
|
Clone Cells | 2 | 2021 | 1760 | 0.670 |
Why?
|
Gene Targeting | 4 | 2017 | 902 | 0.540 |
Why?
|
Targeted Gene Repair | 1 | 2014 | 20 | 0.530 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 25 | 0.520 |
Why?
|
Lentivirus | 5 | 2018 | 534 | 0.390 |
Why?
|
Software | 1 | 2021 | 4396 | 0.300 |
Why?
|
Antigens, CD34 | 3 | 2023 | 664 | 0.300 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 2 | 2017 | 48 | 0.290 |
Why?
|
Zinc Fingers | 3 | 2012 | 595 | 0.250 |
Why?
|
Fanconi Anemia | 2 | 2017 | 322 | 0.240 |
Why?
|
Haemophilus Vaccines | 1 | 2022 | 74 | 0.230 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 60 | 0.230 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2017 | 2480 | 0.210 |
Why?
|
Genome, Human | 1 | 2014 | 4471 | 0.200 |
Why?
|
Genetic Vectors | 5 | 2021 | 3529 | 0.190 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2021 | 133 | 0.190 |
Why?
|
Interleukin Receptor Common gamma Subunit | 3 | 2017 | 85 | 0.190 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 2 | 2012 | 177 | 0.190 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2023 | 5113 | 0.190 |
Why?
|
T-Lymphocytes | 4 | 2022 | 10284 | 0.180 |
Why?
|
DNA, Complementary | 2 | 2022 | 2086 | 0.140 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2013 | 90 | 0.140 |
Why?
|
Cyclosporine | 1 | 2018 | 818 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2018 | 964 | 0.140 |
Why?
|
Gene Transfer Techniques | 4 | 2017 | 1282 | 0.130 |
Why?
|
Adoptive Transfer | 1 | 2017 | 868 | 0.130 |
Why?
|
B-Lymphocyte Subsets | 1 | 2015 | 252 | 0.120 |
Why?
|
Lymphocyte Activation | 2 | 2022 | 5853 | 0.120 |
Why?
|
Mice | 12 | 2022 | 80373 | 0.110 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1575 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2015 | 314 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2946 | 0.110 |
Why?
|
Fetal Blood | 2 | 2017 | 1324 | 0.100 |
Why?
|
Endonucleases | 1 | 2014 | 388 | 0.100 |
Why?
|
Integrases | 2 | 2011 | 548 | 0.100 |
Why?
|
DNA Damage | 2 | 2019 | 2434 | 0.100 |
Why?
|
HIV Integrase | 1 | 2011 | 111 | 0.100 |
Why?
|
Endodeoxyribonucleases | 1 | 2011 | 167 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2017 | 1378 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2019 | 1904 | 0.090 |
Why?
|
Leukemia | 2 | 2021 | 1514 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 2 | 2015 | 1017 | 0.090 |
Why?
|
Antigens, Neoplasm | 2 | 2015 | 1987 | 0.090 |
Why?
|
Mutagenesis, Insertional | 1 | 2011 | 661 | 0.090 |
Why?
|
Mice, SCID | 3 | 2019 | 2787 | 0.080 |
Why?
|
Hematopoiesis | 2 | 2014 | 1994 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1778 | 0.080 |
Why?
|
Multiple Myeloma | 2 | 2017 | 4969 | 0.080 |
Why?
|
Animals | 12 | 2022 | 169404 | 0.080 |
Why?
|
Dependovirus | 3 | 2020 | 733 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2011 | 580 | 0.080 |
Why?
|
Genetic Engineering | 2 | 2015 | 944 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2943 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1893 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3633 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2017 | 5111 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3741 | 0.060 |
Why?
|
Epitopes | 1 | 2011 | 2649 | 0.060 |
Why?
|
Hepatocytes | 1 | 2011 | 1238 | 0.060 |
Why?
|
Sicily | 1 | 2022 | 10 | 0.060 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2022 | 26 | 0.060 |
Why?
|
Vaccines, Combined | 1 | 2022 | 65 | 0.060 |
Why?
|
Immune Tolerance | 1 | 2011 | 2313 | 0.050 |
Why?
|
Hepatitis B Vaccines | 1 | 2022 | 193 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2824 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2022 | 215 | 0.050 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2021 | 45 | 0.050 |
Why?
|
Base Sequence | 3 | 2020 | 13179 | 0.050 |
Why?
|
G2 Phase | 1 | 2020 | 147 | 0.050 |
Why?
|
Cytokines | 1 | 2015 | 7189 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4266 | 0.050 |
Why?
|
Humans | 19 | 2023 | 715818 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2007 | 1373 | 0.050 |
Why?
|
S Phase | 1 | 2020 | 434 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3294 | 0.040 |
Why?
|
DNA Repair | 1 | 2007 | 2034 | 0.040 |
Why?
|
Virus Integration | 2 | 2011 | 300 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2017 | 16735 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 626 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5250 | 0.040 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2013 | 28 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 16575 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2017 | 19905 | 0.030 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2013 | 41 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 2807 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2019 | 15058 | 0.030 |
Why?
|
Interleukin-7 | 1 | 2013 | 144 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2013 | 162 | 0.030 |
Why?
|
Viral Proteins | 1 | 2020 | 1959 | 0.030 |
Why?
|
Lymphoma | 1 | 2021 | 1881 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2020 | 2425 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2012 | 147 | 0.030 |
Why?
|
Antigens, CD | 1 | 2022 | 4152 | 0.030 |
Why?
|
Cell Lineage | 1 | 2020 | 2594 | 0.030 |
Why?
|
Up-Regulation | 1 | 2020 | 4312 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 2938 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 777 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2099 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2430 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29290 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2013 | 1487 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2124 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1726 | 0.020 |
Why?
|
Templates, Genetic | 1 | 2007 | 206 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2011 | 1831 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3964 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7885 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9849 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3844 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2011 | 2758 | 0.020 |
Why?
|
Transgenes | 1 | 2007 | 1014 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3574 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2014 | 1592 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4228 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 24796 | 0.010 |
Why?
|
Binding Sites | 1 | 2011 | 6213 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19537 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1651 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6641 | 0.010 |
Why?
|
Genetic Loci | 1 | 2011 | 2615 | 0.010 |
Why?
|
Infant | 1 | 2022 | 34569 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4918 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9558 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18591 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9799 | 0.010 |
Why?
|
Male | 1 | 2014 | 350352 | 0.010 |
Why?
|
Child | 1 | 2022 | 74468 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 72473 | 0.010 |
Why?
|
Female | 3 | 2018 | 377229 | 0.010 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_